EPAM vs. JNJ

Last updated Jun 13, 2026

EPAM (EPAM Systems, Inc.) and JNJ (Johnson & Johnson) are both stocks. EPAM operates in Information Technology Services (Technology), while JNJ operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, EPAM returned 2.97%/yr vs 10.46%/yr for JNJ. At a 0.19 correlation, their price movements are largely independent.

Performance

EPAM vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in EPAM Systems, Inc. (EPAM) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, EPAM achieves a -53.45% return, which is significantly lower than JNJ's 17.68% return. Over the past 10 years, EPAM has underperformed JNJ with an annualized return of 2.97%, while JNJ has yielded a comparatively higher 10.46% annualized return.

EPAM

• 1D: 2.82%
• 1M: 2.54%
• YTD: -53.45%
• 6M: -54.50%
• 1Y: -44.14%
• 3Y*: -24.19%
• 5Y*: -28.44%
• 10Y*: 2.97%

JNJ

• 1D: 1.07%
• 1M: 6.86%
• YTD: 17.68%
• 6M: 15.11%
• 1Y: 57.15%
• 3Y*: 17.82%
• 5Y*: 10.94%
• 10Y*: 10.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

EPAM vs. JNJ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
EPAM EPAM Systems, Inc.	-53.45%	-12.38%	-21.36%	-9.28%	-50.97%	86.54%	68.91%	82.88%	7.99%	67.05%
JNJ Johnson & Johnson	17.68%	47.48%	-4.81%	-8.58%	5.97%	11.44%	10.82%	16.22%	-5.13%	24.43%

Correlation

The correlation between EPAM and JNJ is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (10Y) Calculated over the trailing 10-year period	0.16
Correlation (All Time) Calculated using the full available price history since Feb 8, 2012	0.19

The correlation between EPAM and JNJ shifts across timeframes, from 0.04 (1 year) to 0.19 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap EPAM : $5.17B JNJ : $588.98B
EPS EPAM : $6.96 JNJ : $8.65
PE Ratio EPAM : 13.70 JNJ : 27.85
PS Ratio EPAM : 0.95 JNJ : 6.08
PB Ratio EPAM : 1.51 JNJ : 7.25
Total Revenue (TTM) EPAM : $5.56B JNJ : $96.36B
Gross Profit (TTM) EPAM : $1.58B JNJ : $66.60B
EBITDA (TTM) EPAM : $670.13M JNJ : $31.62B

Return for Risk

EPAM vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EPAM

EPAM Risk / Return Rank: 7
EPAM Sharpe Ratio Rank: 5
EPAM Sortino Ratio Rank: 7
EPAM Omega Ratio Rank: 7
EPAM Calmar Ratio Rank: 13
EPAM Martin Ratio Rank: 4

JNJ

JNJ Risk / Return Rank: 96
JNJ Sharpe Ratio Rank: 97
JNJ Sortino Ratio Rank: 98
JNJ Omega Ratio Rank: 97
JNJ Calmar Ratio Rank: 93
JNJ Martin Ratio Rank: 94

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EPAM vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for EPAM Systems, Inc. (EPAM) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	EPAM	JNJ	Difference
Sharpe ratio: Return per unit of total volatility	-1.03	3.42	-4.45
Sortino ratio: Return per unit of downside risk	-1.42	4.94	-6.36
Omega ratio: Gain probability vs. loss probability	0.81	1.61	-0.80
Calmar ratio: Return relative to maximum drawdown	-0.77	5.28	-6.05
Martin ratio: Return relative to average drawdown	-1.66	15.52	-17.18

EPAM vs. JNJ - Sharpe Ratio Comparison

The current EPAM Sharpe Ratio is -1.03, which is lower than the JNJ Sharpe Ratio of 3.42. The chart below compares the historical Sharpe Ratios of EPAM and JNJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

EPAM vs. JNJ - Drawdown Comparison

The maximum EPAM drawdown since its inception was -87.50%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for EPAM and JNJ.

Drawdown Indicators

	EPAM	JNJ	Difference
Max Drawdown Largest peak-to-trough decline	-87.50%	-50.67%	-36.83%
Max Drawdown (1Y) Largest decline over 1 year	-59.49%	-10.96%	-48.53%
Max Drawdown (3Y) Largest decline over 3 years	-71.49%	-15.95%	-55.54%
Max Drawdown (5Y) Largest decline over 5 years	-87.50%	-18.41%	-69.09%
Max Drawdown (10Y) Largest decline over 10 years	-87.50%	-27.37%	-60.13%
Current Drawdown Current decline from peak	-86.71%	-2.54%	-84.17%
Average Drawdown Average peak-to-trough decline	-25.77%	-11.90%	-13.87%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.61%	3.72%	+23.89%

Volatility

EPAM vs. JNJ - Volatility Comparison

EPAM Systems, Inc. (EPAM) has a higher volatility of 15.10% compared to Johnson & Johnson (JNJ) at 5.47%. This indicates that EPAM's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	EPAM	JNJ	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.10%	5.47%	+9.63%
Volatility (6M) Calculated over the trailing 6-month period	37.74%	12.16%	+25.58%
Volatility (1Y) Calculated over the trailing 1-year period	44.61%	16.94%	+27.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	54.30%	16.87%	+37.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	45.80%	18.48%	+27.32%

Dividends

EPAM vs. JNJ - Dividend Comparison

EPAM has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 2.18%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EPAM EPAM Systems, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
JNJ Johnson & Johnson	2.18%	2.48%	3.40%	3.00%	2.52%	2.45%	2.53%	2.57%	2.74%	2.38%	2.73%	2.87%

Financials

EPAM vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between EPAM Systems, Inc. and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

EPAM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EPAM Systems, Inc. reported a gross profit of 388.01M and revenue of 1.40B. Therefore, the gross margin over that period was 27.7%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

EPAM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EPAM Systems, Inc. reported an operating income of 116.77M and revenue of 1.40B, resulting in an operating margin of 8.3%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

EPAM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EPAM Systems, Inc. reported a net income of 82.52M and revenue of 1.40B, resulting in a net margin of 5.9%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.

Frequently Asked Questions

Can I hold both EPAM and JNJ in my portfolio?

EPAM and JNJ have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, EPAM or JNJ?

EPAM has higher volatility (15.10%) compared to JNJ (5.47%). In terms of maximum drawdown, EPAM dropped -87.50% vs JNJ's -50.67%.

Which has better risk-adjusted returns?

JNJ currently has the higher Sharpe Ratio (3.42 vs -1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.